EZEDOC 10mg

About

EZEDOC 10mg contains Ezetimibe, a highly selective lipid-lowering agent that operates through a unique mechanism distinct from statins. It specifically targets and inhibits the Niemann-Pick C1-Like 1 (NPC1L1) protein, which is located on the brush border of enterocytes in the small intestine. This protein is crucial for the absorption of dietary and biliary cholesterol, as well as related plant sterols.

By blocking NPC1L1, Ezetimibe effectively reduces the amount of cholesterol absorbed from the gastrointestinal tract, leading to a significant decrease in the delivery of cholesterol to the liver. This reduction in hepatic cholesterol stores prompts the liver to increase its uptake of cholesterol from the bloodstream, primarily by upregulating LDL receptors, thereby lowering plasma levels of LDL-cholesterol (LDL-C), total cholesterol, and triglycerides. Ezetimibe is often used as monotherapy for patients intolerant to statins or in combination with statins to achieve greater LDL-C reduction and improve overall lipid profiles, contributing to a reduced risk of cardiovascular events.

Uses

• Primary hypercholesterolemia (alone or with a statin).
• Homozygous familial hypercholesterolemia (with a statin).
• Homozygous sitosterolemia.
• Reduction of cardiovascular events in patients with coronary heart disease.

Directions For Use

Take one tablet orally once daily, with or without food, at any time of the day.

Benefits

• Significantly lowers LDL-C (bad cholesterol).
• Reduces total cholesterol levels.
• Effective for patients intolerant to statins.
• Can be combined with statins for enhanced effect.
• Reduces the risk of cardiovascular events.
• Well-tolerated with a favorable safety profile.

Side Effects

• Headache
• Abdominal pain
• Diarrhea
• Fatigue
• Muscle pain (myalgia)
• Joint pain (arthralgia)
• Upper respiratory tract infection
• Sinusitis
• Cough
• Nausea
• Dizziness
• Allergic reactions (rare)

Safety Measures

• Alcohol - No specific interaction, but excessive alcohol intake can affect liver function, which is relevant for lipid metabolism.
• Pregnancy - Not recommended during pregnancy due to insufficient data. Use only if clearly needed and potential benefits outweigh risks.
• Breastfeeding - Avoid use during breastfeeding as it is unknown if ezetimibe is excreted in human milk.
• Liver - Use with caution in patients with moderate to severe hepatic impairment. Not recommended in severe liver disease.
• Kidney - No dosage adjustment is required for patients with mild to severe renal impairment.
• Lung - No specific contraindications or safety concerns related to lung conditions.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.